ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.
- Revenue
- +5.93%
- EPS
- +23.1%
- Free cash flow
- −9.79%
- Total debt
- −38.9%
Quarter to September 2026, against a year earlier
Follow RMD
Alert me
ResMed Inc. (RMD) Gross margin
ResMed Inc.'s gross margin over the twelve months to 30 September 2026 was 61.1%, up 0.1 percentage points from fiscal 2026 (61.1%). Over the past ten years it has ranged from 55.8% (fiscal 2023) to 61.1% (fiscal 2026) — the current reading is the highest in ten years. That is above the Medical Instruments & Supplies industry median of 53.6% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2026 | 61.1% | 1.70 |
| FY2025 | 59.4% | 2.69 |
| FY2024 | 56.7% | 0.89 |
| FY2023 | 55.8% | (0.79) |
| FY2022 | 56.6% | (0.96) |
| FY2021 | 57.5% | (0.56) |
| FY2020 | 58.1% | 0.77 |
| FY2019 | 57.3% | 0.28 |
| FY2018 | 57.0% | (1.11) |
| FY2017 | 58.2% | 0.15 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 61.5% | 2.47 |
| Jun 2026 | 59.1% | (3.19) |
| Mar 2026 | 62.3% | 0.49 |
| Dec 2025 | 61.8% | 0.54 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ALGN Align Technology, Inc. compare | 69.1% |
| COO The Cooper Companies, Inc. compare | 65.9% |
| RMD ResMed Inc. | 61.1% |
| ALC Alcon compare | 56.9% |
| BDX Becton, Dickinson and Company compare | 50.3% |
| MDLN Medline Inc. compare | 44.9% |
| WST West Pharmaceutical Services, Inc. compare | 37.6% |
| BAX Baxter International Inc. compare | 30.1% |
| SOLV Solventum Corporation compare | 0.00% |
| Medical Instruments & Supplies industry median | 53.6% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement